What is The Oncology Institute, Inc.'s 2028?

The Oncology Institute, Inc. (TOI) reported 2028 of $2.62M in Q1 2026.

How has The Oncology Institute, Inc.'s 2028 changed year-over-year?

The Oncology Institute, Inc.'s 2028 decreased by 10.8% year-over-year, from $2.93M to $2.62M.

The Oncology Institute, Inc. TOI 2028

2028 at other companies

McKessonMCK

——

Jazz PharmaceuticalsJAZZ

——

Privia Health Group, Inc.PRVA

——

Other financials

Income statement

See full

Revenue$147.4M+41.2%

Operating income-$6.5M+34.3%

Net income-$2.5M+87.3%

EPS (diluted)-$0.02+90.5%

Balance sheet

See full

Cash & equivalents$30.3M-23.8%

Total debt$104.9M+2.5%

Total equity-$16.3M-421%

Total assets$168.2M+2.6%

Cash flow

See full

Operating cash flow-$2.2M+55.6%

CapEx$1.0M+218%

Free cash flow-$3.3M+38.7%

Valuation

See full

Market cap$511.91M+133%

Enterprise value$586.58M+108%

P/S0.9×+0.4×

Profitability

See full

Operating margin-6%-2.1pp

Net margin-8%-2.7pp

FCF margin-5.1%—

Returns & leverage

See full

Return on equity-277.6%-700pp

Debt / equity20.2×+17.3×

Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Oncology Institute, Inc.'s 2028?: The Oncology Institute, Inc. (TOI) reported 2028 of $2.62M in Q1 2026.
How has The Oncology Institute, Inc.'s 2028 changed year-over-year?: The Oncology Institute, Inc.'s 2028 decreased by 10.8% year-over-year, from $2.93M to $2.62M.